{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:48:09Z","timestamp":1791830889809,"version":"4.3.4"},"reference-count":38,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"funding associated"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biopharmaceutical Statistics"],"published-print":{"date-parts":[[2022,7,4]]},"DOI":"10.1080\/10543406.2022.2058529","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T16:55:22Z","timestamp":1653324922000},"page":"529-546","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing"],"prefix":"10.1080","volume":"32","author":[{"given":"Ziyu","family":"Ji","sequence":"first","affiliation":[{"name":"Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7448-2984","authenticated-orcid":false,"given":"Junjing","family":"Lin","sequence":"additional","affiliation":[{"name":"Statistical and Quantitative Sciences, Takeda Pharmaceuticals, Cambridge, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9123-0690","authenticated-orcid":false,"given":"Jianchang","family":"Lin","sequence":"additional","affiliation":[{"name":"Statistical and Quantitative Sciences, Takeda Pharmaceuticals, Cambridge, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28828"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0170-0"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316870"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6426"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/C2009-0-22298-7"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5330"},{"key":"cit0007","unstructured":"European Medicines Agency. ICH E11(R1) guideline on clinical investigation of medicinal products in the pediatric population. Updated September 2017. Accessed July 20, 2021. ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e11r1-guideline-clinical-investigation-medicinal-products-pediatric-population-revision-1_en.pdf"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1002\/0471445428"},{"key":"cit0009","unstructured":"Food and Drug Administration. 2019. Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry. Updated December 2019. Accessed July 20, 2021. https:\/\/www.fda.gov\/media\/78495\/download"},{"key":"cit0010","unstructured":"Food and Drug Administration. 2020. Interacting with the FDA on complex innovative trial designs for drugs and biological products. Updated December 2020. Accessed July 20, 2021. https:\/\/www.fda.gov\/media\/130897\/download"},{"key":"cit0011","unstructured":"Food and Drug Administration. 2021. Reviews of pediatric studies conducted under BPCA and PREA from 2012 \u2013 Present. Updated 24 June 2021. Accessed June 24, 2021. https:\/\/www.fda.gov\/drugs\/development-resources\/reviews-pediatric-studies-conducted-under-bpca-and-prea-2012-present"},{"key":"cit0012","unstructured":"Food and Drug Administration. 2018. Framework for FDA's Real-World Evidence Program. Updated December 2018. Accessed July 20, 2021. https:\/\/www.fda.gov\/media\/120060\/download"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1002\/pst.1807"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1080\/00401706.1991.10484838"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6225"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1002\/sim.8970"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2020.106123"},{"key":"cit0018","volume-title":"External control using RWE and historical data in clinical development. Real-world evidence in drug development and evaluation","author":"Li Q.","year":"2021"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1002\/pst.1879"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2172"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1002\/pst.1918"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2021.1882481"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1002\/sim.9095"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1111\/biom.13252"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1987.10478478"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1002\/pst.175"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216671348"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.2307\/2349003"},{"key":"cit0029","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2020"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1111\/biom.12242"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2008.01048.x"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216631359"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1984"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2019.1657133"},{"key":"cit0035","unstructured":"Weber, S. R bayesian evidence synthesis tools [R package RBesT version 1.6-1]. Published online 2020. Accessed July 29, 2021. https:\/\/CRAN.R-project.org\/package=RBesT"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3140"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2143"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2039"}],"container-title":["Journal of Biopharmaceutical Statistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10543406.2022.2058529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T07:26:09Z","timestamp":1661325969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10543406.2022.2058529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7,4]]}},"alternative-id":["10.1080\/10543406.2022.2058529"],"URL":"https:\/\/doi.org\/10.1080\/10543406.2022.2058529","relation":{},"ISSN":["1054-3406","1520-5711"],"issn-type":[{"value":"1054-3406","type":"print"},{"value":"1520-5711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lbps20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lbps20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}